Alpha Tau Medical (DRTS) Capital Expenditures (2021 - 2022)

Alpha Tau Medical (DRTS) posted Capital Expenditures of -$377000.0 for Q2 2022, down 26.51% sequentially from -$298000.0 in Q1 2022.

Alpha Tau Medical (DRTS) Capital Expenditures (2021 - 2022) Analysis & Trends

Alpha Tau Medical has reported Capital Expenditures for 2 years, with the latest figure at -$377000.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	112.20 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	240.20 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	2.29 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	25.02 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	572,662.23
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	251.02 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	34.68 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	6.26 Mn
10	Alpha Tau Medical	1.32 Bn	1.32 Bn	-	-

Download Data